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Introduction
Drug addiction is defined as a compulsive pattern of drug-seeking-and taking-behavior, with recurrent episodes of abstinence and relapse, and a loss of control despite negative consequences. A current hypothesis is that persistent behavioral alterations characterizing addiction result from drug-evoked long-term changes in synaptic efficacy involving the early recruitment of specific signaling cascade and gene expression (1) . This continuum between synaptic and nuclear events shapes an enduring remodeling of the reward circuitry likely involved in the transition from casual drug use to addiction (2)(3)(4). This drug-induced memory trace is persistent and tightly related to the context of drug consumption, partly explaining the high risk of relapse even after long periods of abstinence. Addictive drugs promote reinforcement by increasing dopamine (DA) in the mesocorticolimbic system (5) , which alters excitatory glutamate transmission within the reward circuitry and hijacks reward processing (1) . The striatum is a key target structure of drugs of abuse since it is at the crossroad of converging glutamate inputs from limbic, thalamic and cortical regions, encoding components of drug-associated stimuli and environment, and DA that mediates reward prediction error and incentive values. These signals are integrated in GABAergic striatal projection neurons (SPN), which receive glutamate and DA axons converging onto their dendritic spines (6) (7) . SPN primarily form two mostly distinct populations based on the expression of either DA-D1 (D1R) or DA-D2 (D2R) receptors (8) (9) which are G protein-coupled receptors (GPCR) positively and negatively modulating adenylyl cyclase though their respective coupling to G s/olf and G i/o subtypes (10) (11) .
While a classical view is that the two populations of SPNs act in parallel, playing antagonistic functional roles, the picture seems much more complex as discussed below.
Initial studies based on the use of DA receptor agonists or antagonists led to somewhat confounding results on the role of D1R-and D2R-SPN in drug-evoked adaptations (12) . A major limitation of such strategies is the widespread effect of these compounds in the brain, with different specificity, pharmacokinetics and downstream effects relative to pre-and post-synaptic receptors. Analyzing molecular events in identified neuronal populations was made possible by the development of reporter mouse lines expressing fluorescent proteins or cre-recombinase under the control of cell-specific promoters, drd1a and drd2/Adora2a for D1R-SPNs and D2R-SPNs, respectively (13)(14)(15)(16) (17) . From circuits to molecules, cell-type-specific manipulations are now achievable owing to targeted chemogenetic and optogenetic technologies, conditional knock-out, or acting on specific protein-protein interactions. This deepened our understanding of the differential impact of drug exposure on these two neuronal populations, from alterations of the inputs they receive to the pattern of signaling cascades and transcriptional landscape they exhibit at various stages of addiction. Focusing on studies using the psychostimulants cocaine and amphetamine, which constitute the vast majority of the work regarding cellspecific functions in addiction, we discuss the literature linking drug-induced behavioral alterations with adaptations in D1R-SPN and D2R-SPN at the circuit, cellular and molecular levels.
Cell-type-specific modulation of SPN activity
A current hypothesis is that the transition from recreational to compulsive drug use relies on a gradual recruitment from ventromedial to dorsolateral striatal sub-regions (18) (19) . Despite the existence of behavioral features of vulnerability towards addiction (19) , few preclinical studies support the intriguing possibility that individuals which develop behavioral traits of addiction display plasticity-related alterations in the striatum (20) .
Nonetheless, most studies have focused on remodeling of neural circuits in the ventral striatum (i.e nucleus accumbens; NAc) and dorsomedial striatum (DMS) induced by early drug exposure (Table S1 ), which does not reflect addiction per se, but might constitute a main trigger towards drug abuse. SPN constitute 95% of striatal neurons, the remaining 5% being local interneurons, which include large tonically-active cholinergic interneurons (CIN). Even though CIN are major players in the modulation of striatal microcircuits (21) , their implication in drug responses is out of the scope of the current review.
In the dorsal striatum (DS), a common view is that D1R-SPN and D2R-SPN exert opposite effects through distinct output projections, with D2R-SPN reaching the midbrain through polysynaptic projections via the external Globus Pallidus (GPe) (indirect pathway), while D1R-SPN directly project onto the internal Globus Pallidus and the Substantia Nigra (direct pathway). However, a subset of D1R-SPN displays projections to the GPe (22) , which can be augmented under certain conditions (23). This dichotomy becomes even more erroneous regarding the NAc since 2-5% of core SPN express both DA receptors (24) (25) , while in the Shell, this proportion varies from 2-5% (25) up to 10-15% (24), depending on the methodologies used.
Moreover, even though there exists a recent controversy as whether they constitute a distinct subpopulation or whether they form collaterals, a large proportion of NAc D1R-SPN projects in the ventral pallidum (VP), which is the canonical output of D2R-SPN (25)(26) (27) .
Consistent with the so-called "Go/NoGo" model of basal ganglia in which D1R-SPN and D2R-SPN activity facilitates and inhibits movement planning/initiation, respectively (28)(29)(30), cell-type-specific manipulations initially supported that SPNs from the NAc and DMS play antagonistic roles on reward processing, including drug-induced behaviors (31) (32) . Indeed, the selective ablation of NAc D2R-SPN (17) or their transient chemogenetic inhibition in the DS (33) enhances psychostimulant-induced CPP and locomotor sensitization, respectively. In opposite, D2R-SPN chemogenetic activation in the entire striatum blocks amphetamine-induced sensitization (34) , while their optogenetic stimulation in the NAc reduces cocaine CPP (31) and alleviates locomotor sensitization when applied during the withdrawal period (35) . On the other hand, optogenetic activation of NAc D1R-SPN enhances cocaine-induced CPP (31), whereas their inhibition in the DS (33) or the NAc (36)(37), or their reversible blockade in the entire striatum (38) decreases psychostimulant-induced locomotor sensitization or CPP. Regarding operant behavior, NAc D2R-SPN chemogenetic inhibition enhances motivation to obtain cocaine while their activation by optogenetics diminishes drug-seeking (39) . In opposite, chemogenetic inhibition of D1R-SPN in the DMS reduces cue-induced reinstatement of cocaine-seeking, while sparing escalation, maintenance, and incentive components (40) .
Altogether, these studies support a binary model in which D1R-SPN and D2R-SPN primarily form two parallel pathways promoting and reducing psychostimulant-induced adaptations, respectively. However, this dichotomic view overlooks several anatomo-functional findings. Notably, selective inhibition of NAc D1R-SPN projections to the VP, reduces cue-induced reinstatement of cocaine-seeking, suggesting that specific D1R-SPN projections might control distinct components of addictive behaviors (26) . Accordingly, stimulating NAc shell projections to lateral hypothalamus (likely originating from D1R-SPN (41)) enhances the motivation to self-administer cocaine and facilitates drug-seeking, while global NAc shell activation accelerates extinction of this behavior (42) . This latter finding could result from the concomitant stimulation of both SPN populations, which is likely to differentially impact striatal microcircuits. Along the same line, the "lateral inhibition" of D2R-SPN onto D1R-SPN in the NAc appears as a major mechanism by which D2R-SPN could participate to locomotor sensitization by favoring D1R-SPN activity (43) (44) . Moreover, cocaine can inhibit D2R-SPN synaptic transmission onto VP neurons in a DA-independent but serotonin-dependent manner (45) , the behavioral consequences of which remain unknown. Functionally, other findings challenge the view of opposite actions of the two SPN populations on drug-induced behavioral adaptations. In the DMS, ablation of D1R-SPN decreases acute amphetamineinduced locomotor response without affecting sensitization, whereas ablating D2R-SPN decreases sensitization but spares acute locomotor responses (46) . Similarly, the transient inhibition of synaptic transmission of D2R-SPN in the DMS delays the development of locomotor sensitization, although to a lower extent than D1R-SPN inhibition (38) .
Studies on the control of non-drug reward processing reinforce the controversy regarding the antagonistic roles of the two SPN populations. Indeed, optogenetic-mediated manipulations of D1R-SPN and D2R-SPN suggest that they can both mediate "pro-rewarding" effects (47)(48)(49)(50)(51)(52), or "aversion" depending on the type of manipulation (53) , even though chemogenetic inhibition of D2R-SPN leads to discrepant results (54) (55) . These studies highlight that D1R-SPN and D2R-SPN may rather act in a dynamic and concerted fashion to control behavior. Accordingly, both populations are activated at the same time in the DLS during initiation of a reward-oriented action (56) (49) , which has been proposed to allow proper action sequence initiation (57) . In addition to challenging the antagonism of both SPN populations, these findings call for caution regarding the interpretation of the results obtained by direct manipulations of SPN on drug-related behaviors since they could result from perturbations of reward processing per se, rather than reflecting specific alterations Neurons specifically contacting each SPN subpopulation display distinct drug-induced structural plasticity, supporting input-specific alterations (60) . In accordance Luscher's group showed that cocaine-induced locomotor sensitization is associated with a potentiation of excitatory cortical inputs onto D1R-SPN, but not D2R-SPN, of the NAc. Optogenetically-induced depotentiation of these synapses established the causality between drug-evoked plasticity in D1R-SPN and behavioral sensitization (61) . They also showed that mice trained to self-administer cocaine and subjected to a 30-day withdrawal display a potentiation of transmission at ventral hippocampal and cortical, but not amygdalar, excitatory projections onto NAc D1R-SPN. Specific optogenetically-induced patterns of stimulation decrease vigor response and abolish cocaine-seeking when hippocampal and cortical inputs are depotentiated, respectively (62) . The same group also showed that compulsive self-stimulation of DA transmission, which models drug addiction, relies on the potentiation of excitatory projections from the orbitofrontal cortex onto D1R-SPNs of the ventro-central striatum (63) . These studies highlight that distinct components of drug addiction rely on drug-evoked synaptic adaptations at specific input projections onto D1R-SPN. Accordingly, repeated cocaine exposure strengthens afferences from the basolateral amygdala onto D1R-SPN but not D2R-SPN (64) . Inputs onto D2R-SPN also seem to be altered by drug exposure since cocaine-induced CPP correlates with a strengthening of the coupling between hippocampal place cells and D2R-SPN (65) . However, further studies are necessary to establish causality between neurobiological adaptations onto D2R-SPN and addictive behavior.
Beyond the comprehension of the mechanisms that underlie addiction, unraveling the precise alterations in synaptic connectivity between SPN and input areas could inspire therapeutic strategies to reverse drug-induced synaptic changes, for instance through deep-brain or transcranial magnetic stimulation (66) (67) . Moreover, the identification of specific drug-evoked synaptic changes highlights that addiction involves perturbation in the balance between glutamatergic inputs and DA modulatory signaling onto SPN. This calls for a better understanding of the underlying molecular mechanisms as it may lead to identification of innovative molecular target (68). (36) . The mechanisms by which DA controls Ca 2+ signaling were initially investigated through cell-specific overexpression in D1R-SPN of NMDA glutamate receptor (NMDAR) bearing reduced Ca 2+ permeability, which prevents the sensitizing and rewarding effects of cocaine (74), whereas the same manipulation in D2R-SPN did not impact amphetamine-mediated CPP (75) . NMDAR knock-out in D1Rexpressing cells also blocks amphetamine-induced sensitization, a phenotype that is rescued by restoring functional NMDAR in NAc D1R-SPN or deleting NMDAR in all SPN (76) . By contrast, NMDAR knock-out in either D1R-or A2AR-(overlapping with D2R-SPN) cells, or both, preserves the development and extinction of cocaine-induced CPP (77) . However, NMDAR deletion in D1R-, but not A2AR-, cells blunts CPP reinstatement, which is partially rescued by full NMDAR deletion (77) . These findings highlight the critical role of a balanced NMDAR activity in each cell-types for drug-induced responses. Although constitutive, and not striatal-specific, these manipulations support a critical role of striatal DA and NMDAR signaling crosstalk in drug-evoked responses.
Cell-type-specific striatal signaling from the membrane towards the nucleus
Downstream from these receptors, the extracellular-signal regulated kinase (ERK) pathway is activated by virtually all drugs of abuse (78) . Global ERK inhibition blocks long-term potentiation of glutamate synapses impinging onto D1R-SPN (61), cocaine-induced locomotor sensitization and CPP (79)(80) and the reconsolidation of drug-associated memories (81) (82) . Acute cocaine activates ERK in D1R-SPN (24) via a mechanism that depends on both D1R and NMDAR (79) (83) . ERK activation thus behaves as a coincidence detector of glutamate and DA signaling (84) . This occurs through a cAMP-independent and D1R-mediated facilitation of GluN2B-containing NMDAR, triggering Ca 2+ -dependent ERK activation (83)(85)(86) ( Figure 1 ).
Nevertheless, inhibiting D1R-mediated potentiation of NMDAR targeting ERK activation in D1R-SPN blocks
the sensitizing and rewarding effects of cocaine (83) . We also found that in NAc shell D1R-SPN, acute cocaine triggers rapid de novo formation of dendritic spines contacting pre-existing glutamate axon terminals (87) .
Stabilization of these newly-formed synapses requires the targeting of the cytoplasmic mitogen-activated protein kinase interacting protein-1 (MNK-1) by ERK, which controls local translation independently of nuclear events, and likely influences responses to subsequent drug exposure (87) .
Downstream from D1R, the cAMP/PKA pathway also contributes to the facilitation of NMDAR functions by directly targeting specific subunits (88) . Although PKA cannot directly target ERK, it can indirectly amplify its activation, notably via the cAMP-regulated phosphoprotein (DARPP-32), as described in (89)(85) Despite the importance of the crosstalk between striatal DA and glutamate signaling for drug-induced adaptations, targeting of cognate receptors in human to alleviate addiction led to a lack of efficacy and/or side effects over time (86) , likely due to perturbation of crucial physiological functions. The development of biased ligands, recruiting specific pathways, opens the way towards the modulation of specific behavioral components (94) . Little is known about their relevance in addiction, notably whether they could alleviate specific drugevoked behavioral components, while sparing non-drug reward processing remains to be established.
Interestingly, transgenic approaches show that biasing D2R towards arrestin signaling in the NAc affects cocaine-induced locomotion but not reward processing (95) .
The physical interaction of DA receptors with other receptors also appears as a powerful mechanism by which receptors can mutually modify their functions through allosteric interactions resulting in functional selectivity.
Hence, receptor heteromers are emerging as promising targets for fine-tuning of specific signaling pathways (96)(97)(98). One of the best characterized receptor complexes are D2R-A2AR heteromers that are detected in vivo in the striatum (99) and which implication in reward and addiction is well-reviewed (100) (98) . The key role of DAR-NMDAR interaction for their reciprocal modulation (101)(102)(103)(104) 109)(110)(110). Cocaine-triggered Elk-1 phosphorylation downstream D1R regulates the induction of immediate early genes (IEG), including c-Fos and Zif268 (110) . As a consequence, inhibiting ERK-mediated Elk-1 phosphorylation blunts the sensitizing and rewarding effects of cocaine (109) . By contrast, msk1-deficient mice, which show altered histone H3 phosphorylation (a major cocaine-induced epigenetic mark in D1R-SPN (24)(111)), exhibit a downregulation of c-Fos and dynorphin, but not Zif268, expression, along with decreased locomotor sensitization but spared CPP (111) .
Genetic and Epigenetic regulation
The contribution of D1R-SPN-induced genes was initially established at the level of IEG through pharmacological studies and further confirmed using reporter mice (24) Cell-type-specific genome-wide approaches, including FACS-array profiling from D1R-SPN and D2R-SPN reporter lines (130) or cell-type-specific affinity purification of polysomal mRNAs (117) , revealed major differences in transcriptional landscapes between each subpopulation. A similar approach based on the use of Ribotag mice identified the transcription factor "early growth response 3 (Egr3) as differentially regulated by chronic cocaine in the two SPN subtypes with an increase in D1R-SPN and a decrease in D2R-SPN (131) .
Chromatin Immunoprecipitation (ChiP) demonstrated the binding of Egr3 to promoters of neuronal plasticityassociated genes (CamK2α, CREB), which were further shown increased in D1R-SPN and decreased in D2R-
SPN (131)
The persistent and experience-dependent features of addiction have suggested a role for epigenetic modifications, as they mediate stable transcriptional alterations supporting long-term remodeling of neuronal networks (4) . Drugs affect multiple epigenetics processes including histones post-translational modifications (PTM), long-range chromatin reorganization and non-coding RNAs (132) .
Histones PTM, including acetylation, methylation or phosphorylation, gate DNA accessibility for transcription (133) and have been extensively studied in addiction (134) . In particular, cocaine exposure induces a global increase in H3 and H4 acetylation (135)(136)(137), a transcription-permissive epigenetic mark (138) . ChiPbased analyses have been instrumental in understanding the contribution of these epigenetic changes to specific candidate gene regulation (132) , as illustrated by H4 hyper-acetylation at the cfos promoter after acute, but not chronic, cocaine exposure (135) . A genome-wide analysis of H3 and H4 pan-acetylation extended the mapping of cocaine-induced histone acetylation alterations at many genes predominantly induced in D1R-SPN including arc, cfos, egr3 (137) . Direct assessment of cell-specific histone acetylation on FACS-sorted D1R-SPN or D2R-SPN (139) shows an increase in H3 and H4 acetylation in both population after acute cocaine, while H4 acetylation remain enriched only in D2R-SPN after chronic treatment. This study also confirms the D1R-SPNspecific increase in Ser10-PH3 associated with c-fos transcriptional activation (140) .
Histone lysine methylation is another cocaine-regulated modification that can either activate or repress transcription depending on the specific Lysine (K) residue targeted and its valence of methylation (141) . In the NAc, chronic cocaine decreases the global level of di-and tri-methylation of H3K9 residue and down-regulates its catalyzing enzymes, G9a histone methyl-transferase (142) . A ribosomal affinity purification approach shows that G9a expression is predominantly affected in D2R-SPN in the whole striatum after cocaine exposure, and its specific knockdown in D2R-SPN shifts these SPNs to a D1R-SPN phenotype, resulting in enhanced response to cocaine (143) . NAc-specific profiling further demonstrates that the reduction of G9a specifically occurs in D1R-SPN (144) (131) . Similarly, histone lysine methylation profile shows cell-specific regulations, depending on time and regimen of cocaine (139) (see table) . Arginine methylation is decreased in D2R-SPN together with downregulation of both protein-R-methyltransferase6 (PRMT6) and its associated mark, asymmetric demethylation of R2 on histone H3 (H3R2me2a), after repeated exposure to cocaine (145) . While direct methylation of DNA at specific promoter regions also plays a key role in gene regulation and cocaine-related behaviors (4), its cell-type-specificity is yet unknown.
Growing evidences suggest a critical role for persistent changes in chromatin architecture in modulating subsequent neuronal responses during drug re-exposure via a mechanism referred to as "gene priming". This process could be involved in cell-type-specific long-term transcriptional alterations as recent observations show differential changes in chromatin accessibility between D1R-SPN and D2R-SPN after chronic cocaine (146) .
Overall these data indicate that epigenetic remodeling could be critical in shaping the transcriptional program of D1R-SPN and D2R-SPN, although further investigations are now required to understand the cell-specific contribution of these processes.
Finally, much attention has been paid to micro-RNAs (miRNA), a category of 21-25 nucleotides non-coding RNAs, which are altered in several psychiatric conditions (147) , including addiction (148) . MiRNA, by repressing mRNA translation (149) , are considered as "master regulators" of long-lasting transcriptional adaptations. MiRNA-mediated gene regulation plays a role in cocaine-related changes in neurotransmission and behavior (149) but their cell-type-specific role in the striatum remains unknown. One study began to broadly address this issue by ablating a key protein in miRNA processing, Ago2, in D2R-SPN (150) . These mice showed loss of motivation to self-administer cocaine and a decrease of 23 miRNAs (out of 63) induced by acute cocaine.
The question as to whether and how miRNAs regulation in D1R-SPN occurs, along with the specific role of miRNAs in this neuronal population remains be established.
Conclusions and perspectives
While converging data point at a critical role for D1R-SPN-specific plasticity, cell-type-specific approaches reveal evident molecular alterations in D2R-SPNs in favor of their active role in the reshaping of striatal circuits in addiction. However, we still lack a comprehensive model for the contribution of intracellular pathways involved in drug-induced transcriptional alterations in D1R-SPN and D2R-SPN at various stages of addiction.
Cell-type-specific approaches and timed-controlled interventions coupled to genome-wide analysis of gene expression, epigenetic marks and chromatin structure should deepen our understanding of the synergistic role of these two populations in drug-induced behavioral alterations. Establishing causality between drug-induced behavioral adaptations and discrete molecular and cellular mechanisms specific to each SPN population could allow the design of novel treatment strategies to alleviate selective behavioral components of addiction. 
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